価格表

在庫・価格 : 2025年04月29日 23時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-CD2, Mouse-Mono(B-E2), Azide free <Anti-LFA-2>
データシート※最新のデータシートでない場合があります
852.500.000 TLSダイアクローン
Diaclone SAS
200 μl 本製品は取扱中止になりました 追加

在庫・価格 : 2025年04月29日 23時55分 現在

Anti-CD2, Mouse-Mono(B-E2), Azide free <Anti-LFA-2>

  • 商品コード:852.500.000
  • メーカー:TLS
  • 包装:200μl
  • 本製品は取扱中止になりました
使用文献
No. 文献情報 備考 参照
1 Cavazzana-Calvo M et al. A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Soci&#xE9;t&#xE9; Fran&#xE7;ais
Cavazzana-Calvo M et al
1996/01/01
Application: Given to inhibit T and NK cell proliferation PubMed
2 Dupuis-Girod S et al. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency. Pediatrics 2006 Jul;118(1):e205-11
Dupuis-Girod S et al
2006/01/01
Application: Given to inhibit T and NK cell proliferation PubMed
3 Jabado N et al. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood 1997 Dec;90(12):4743-8
Jabado N et al
1997/01/01
Application: Given to inhibit T and NK cell proliferation PubMed
4 Tiberghien P et al. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 2001 Jan;97(1):63-72
Tiberghien P et al
2001/01/01
Application: Given to inhibit T and NK cell proliferation PubMed
5 Przepiorka D et al. A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease. Blood 1998 Dec;92(11):4066-71
Przepiorka D et al
1998/01/01
Application: Not a use just reference PubMed
6 Racadot E et al. Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients. Bone Marrow Transplant. 1995 May;15(5):669-77
Racadot E et al
1995/01/01
PubMed
7 Jabado N et al. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Pediatrics 1996 Sep;
Jabado N et al
1996/01/01
PubMed
  • No.: 1
  • 文献情報:
    Cavazzana-Calvo M et al. A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Soci&#xE9;t&#xE9; Fran&#xE7;ais
    Cavazzana-Calvo M et al
    1996/01/01
  • 備考:
    Application: Given to inhibit T and NK cell proliferation
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Dupuis-Girod S et al. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency. Pediatrics 2006 Jul;118(1):e205-11
    Dupuis-Girod S et al
    2006/01/01
  • 備考:
    Application: Given to inhibit T and NK cell proliferation
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Jabado N et al. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood 1997 Dec;90(12):4743-8
    Jabado N et al
    1997/01/01
  • 備考:
    Application: Given to inhibit T and NK cell proliferation
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Tiberghien P et al. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft. Blood 2001 Jan;97(1):63-72
    Tiberghien P et al
    2001/01/01
  • 備考:
    Application: Given to inhibit T and NK cell proliferation
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Przepiorka D et al. A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease. Blood 1998 Dec;92(11):4066-71
    Przepiorka D et al
    1998/01/01
  • 備考:
    Application: Not a use just reference
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Racadot E et al. Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients. Bone Marrow Transplant. 1995 May;15(5):669-77
    Racadot E et al
    1995/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Jabado N et al. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Pediatrics 1996 Sep;
    Jabado N et al
    1996/01/01
  • 備考:
  • 参照:
    PubMed